FREE ELECTRONIC LIBRARY - Dissertations, online materials

Pages:   || 2 | 3 | 4 | 5 |   ...   | 13 |

«AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 08: Functional Limitations and Disability ...»

-- [ Page 1 ] --

AHRQ Healthcare Horizon Scanning System – Potential

High-Impact Interventions Report

Priority Area 08: Functional Limitations and Disability

Prepared for:

Agency for Healthcare Research and Quality

U.S. Department of Health and Human Services

540 Gaither Road

Rockville, MD 20850


Contract No. HHSA290-2010-00006-C

Prepared by:

ECRI Institute

5200 Butler Pike

Plymouth Meeting, PA 19462

June 2015

Statement of Funding and Purpose This report incorporates data collected during implementation of the Agency for Healthcare Research and Quality (AHRQ) Healthcare Horizon Scanning System by ECRI Institute under contract to AHRQ, Rockville, MD (Contract No. HHSA290-2010-00006-C). The findings and conclusions in this document are those of the authors, who are responsible for its content, and do not necessarily represent the views of AHRQ. No statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services.

This report’s content should not be construed as either endorsements or rejections of specific interventions. As topics are entered into the System, individual topic profiles are developed for technologies and programs that appear to be close to diffusion into practice in the United States.

Those reports are sent to various experts with clinical, health systems, health administration, and/or research backgrounds for comment and opinions about potential for impact. The comments and opinions received are then considered and synthesized by ECRI Institute to identify interventions that experts deemed, through the comment process, to have potential for high impact. Please see the methods section for more details about this process. This report is produced twice annually and topics included may change depending on expert comments received on interventions issued for comment during the preceding 6 months.

A representative from AHRQ served as a Contracting Officer’s Technical Representative and provided input during the implementation of the horizon scanning system. AHRQ did not directly participate in horizon scanning, assessing the leads for topics, or providing opinions regarding potential impact of interventions.

Disclaimer Regarding 508-Compliance Individuals using assistive technology may not be able to fully access information in this report. For assistance contact info@ahrq.gov.

Financial Disclosure Statement None of the individuals compiling this information has any affiliations or financial involvement that conflicts with the material presented in this report.

Public Domain Notice This document is in the public domain and may be used and reprinted without special permission.

Citation of the source is appreciated.

Suggested citation: ECRI Institute. AHRQ Healthcare Horizon Scanning System Potential HighImpact Interventions: Priority Area 08: Functional Limitations. (Prepared by ECRI Institute under Contract No. HHSA290-2010-00006-C.) Rockville, MD: Agency for Healthcare Research and Quality. June 2015. http://effectivehealthcare.ahrq.gov/index.cfm/ i Preface The purpose of the AHRQ Healthcare Horizon Scanning System is to conduct horizon scanning of emerging health care technologies and innovations to better inform patient-centered outcomes research investments at AHRQ through the Effective Health Care Program. The Healthcare Horizon Scanning System provides AHRQ a systematic process to identify and monitor emerging technologies and innovations in health care and to create an inventory of interventions that have the highest potential for impact on clinical care, the health care system, patient outcomes, and costs. It will also be a tool for the public to identify and find information on new health care technologies and interventions. Any investigator or funder of research will be able to use the AHRQ Healthcare Horizon Scanning System to select potential topics for research.

The health care technologies and innovations of interest for horizon scanning are those that have yet to diffuse into or become part of established health care practice. These health care interventions are still in the early stages of development or adoption, except in the case of new applications of already-diffused technologies. Consistent with the definitions of health care interventions provided by the National Academy of Medicine (formerly the Institute of Medicine) and the Federal Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening and diagnostic tests, procedures, services and programs, and care delivery.

Horizon scanning involves two processes. The first is identifying and monitoring new and evolving health care interventions that are purported to or may hold potential to diagnose, treat, or otherwise manage a particular condition or to improve care delivery for a variety of conditions. The second is analyzing the relevant health care context in which these new and evolving interventions exist to understand their potential impact on clinical care, the health care system, patient outcomes, and costs. It is NOT the goal of the AHRQ Healthcare Horizon Scanning System to make predictions on the future use and costs of any health care technology. Rather, the reports will help to inform and guide the planning and prioritization of research resources.

We welcome comments on this Potential High-Impact Interventions report. Send comments by mail to the Task Order Officer named in this report to: Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, MD 20850, or by email to: effectivehealthcare@ahrq.hhs.gov.

–  –  –

ii Contents Executive Summary





Central Nervous System Disorder Intervention

Daclizumab (Zinbryta) for Treatment-Refractory Relapsing- Remitting Multiple Sclerosis........ 2 Genetic Disorder Interventions

Conestat Alfa (Ruconest) for Treatment of Acute Hereditary Angioedema

Eliglustat Tartrate (Cerdelga) for Treatment of Gaucher’s Disease Type 1

Elosulfase Alfa (Vimizim) for Treatment of Morquio A Syndrome

Exon-Skipping Therapies (Drisapersen and Eteplirsen) for Treatment of Duchenne Muscular Dystrophy

Idebenone (Catena) for Treatment of Duchenne Muscular Dystrophy

L-Glutamine for Prevention of Vaso-Occlusive Crises in Sickle Cell Disease

Migalastat Hydrochloride (Galafold) for Treatment of Fabry Disease

Sensory Disorder Interventions

Pediatric Vision Scanner Screening for Strabismus and Amblyopia

Tasimelteon (Hetlioz) for Treatment of Non–24-Hour Sleep-Wake Disorder

Spinal Cord Injury Intervention

Intraoral Tongue-Drive Computerized System to Maneuver Electric Wheelchairs

Wearable, Battery-Powered Exoskeleton (ReWalk Personal) To Enable Mobility in Community or Home Settings in Patients With Paraplegia

Upper Limb Amputation Intervention

Prosthetic Arm with Body-Machine Interface (DEKA Arm System) to Restore Natural Arm Function After Amputation


Figures Figure 1. Overall high-impact potential: daclizumab (Zinbryta) for treatment-refractory relapsing-remitting multiple sclerosis

Figure 2. Overall high-impact potential: conestat alfa (Ruconest) for treatment of acute hereditary angioedema

Figure 3. Overall high-impact potential: eliglustat tartrate (Cerdelga) for treatment of Gaucher’s disease type 1

iii Figure 4. Overall high-impact potential: elosulfase alfa (Vimizim) for treatment of Morquio A syndrome

Figure 5. Overall high-impact potential: exon-skipping therapies (eteplirsen and drisapersen) for treatment of Duchenne muscular dystrophy

Figure 6. Overall high-impact potential: idebenone (Catena) for treatment of Duchenne muscular dystrophy

Figure 7. Overall high-impact potential: L-glutamine for prevention of vaso-occlusive crises in sickle cell anemia

Figure 8. Overall high-impact potential: migalastat hydrochloride for treatment of Fabry disease

Figure 9. Overall high-impact potential: Pediatric Vision Scanner screening for strabismus and amblyopia

Figure 10. Overall high-impact potential: tasimelteon (Hetlioz) for treatment of non–24-hour sleep-wake disorder

Figure 11. Overall high-impact potential: intraoral tongue-drive computerized system to maneuver electric wheelchairs

Figure 12. Overall high-impact potential: wearable, battery-powered exoskeleton (ReWalk Personal) to enable mobility in community or home settings in patients with paraplegia

Figure 13. Overall high-impact potential: prosthetic arm with body-machine interface (DEKA Arm System) to restore natural arm function after amputation

iv Executive Summary Background Horizon scanning is an activity undertaken to identify technological and system innovations that could have important impacts or bring about paradigm shifts. In the health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic interventions, rehabilitative interventions, behavioral health interventions, and public health and health promotion activities. In early 2010, the Agency for Healthcare Research and Quality (AHRQ) identified the need to establish a national Healthcare Horizon Scanning System to generate information to inform comparative-effectiveness research investments by AHRQ and other interested entities. AHRQ makes those investments in 14 priority areas. For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address unmet needs. Thus, we refer to topics identified and tracked in the AHRQ Healthcare Horizon Scanning System generically as “interventions.” The AHRQ Healthcare Horizon Scanning System implementation of a systematic horizon scanning protocol (developed between September 1 and November 30, 2010) began on December 1, 2010. The system is intended to identify interventions that purport to address an unmet need and are up to 3 years out on the horizon and then to follow them up to 2 years after initial entry into the health care system.

Since that implementation, review of more than 21,000 leads about potential topics has resulted in identification and tracking of about 2,250 topics across the 14 AHRQ priority areas and 1 crosscutting area; more than 600 topics are being actively tracked in the system.

Methods As part of the Healthcare Horizon Scanning System activity, a report on interventions deemed as having potential for high impact on some aspect of health care or the health care system (e.g., patient outcomes, utilization, infrastructure, costs) is aggregated twice a year. Topics eligible for inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase III trials or for which some preliminary efficacy data in the target population are available) in the United States or that have just begun diffusing and that have completed an expert feedback loop.

The determination of impact is made using a systematic process that involves compiling information on topics and issuing topic drafts to a small group of various experts (selected topic by topic) to gather their opinions and impressions about potential impact. Those impressions are used to determine potential impact. Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the same class are read separately), and then topics in the same class of a device, drug, or biologic are aggregated for discussion and impact assessment at a class level for this report. The process uses a topic-specific structured form with text boxes for comments and a scoring system (1 minimal to 4 high) for potential impact in seven parameters. Participants are required to respond to all parameters.

The scores and opinions are then synthesized to discern those topics deemed by experts to have potential for high impact in one or more of the parameters. Experts are drawn from an expanding database ECRI Institute maintains of approximately 170 experts nationwide who were invited and agreed to participate. The experts comprise a range of generalists and specialists in the health care sector whose experience reflects clinical practice, clinical research, health care delivery, health business, health technology assessment, or health facility administration perspectives. Each expert uses the structured form to also disclose any potential intellectual or financial conflicts of interest ES-1 (COIs). Perspectives of an expert with a COI are balanced by perspectives of experts without COIs.

No more than two experts with a possible COI are considered out of a total of the five to eight experts who are sought to provide comment for each topic. Experts are identified in the system by the perspective they bring (e.g., clinical, research, health systems, health business, health administration, health policy).

The topics included in this report had scores and/or supporting rationales at or above the overall average for all topics in this priority area that received comments by experts. Of key importance is that topic scores alone are not the sole criterion for inclusion—experts’ rationales are the main drivers for the designation of potentially high impact. We then associated topics that emerged as having potentially high impact with a further subcategorization of “lower,” “moderate,” or “higher” within the high-impact-potential range. As the Healthcare Horizon Scanning System grows in number of topics on which expert opinions are received and as the development status of the interventions changes, the list of topics designated as having potentially high impact is expected to change over time. This report is being generated twice a year.

For additional details on methods, please refer to the full AHRQ Healthcare Horizon Scanning System Protocol and Operations Manual published on AHRQ’s Effective Health Care Web site.

Pages:   || 2 | 3 | 4 | 5 |   ...   | 13 |

Similar works:

«Best Practice Breastfeeding Questions and Answers Information for Health Professionals for Baby-Friendly Assessment 1. Where would you find a copy of the breastfeeding policy? Intranet, Breastfeeding Resource Book, Policy and Procedure Manual 2. What is the infant feeding policy? “Children’s and Women’s Hospital promotes a philosophy of maternal and infant care which advocates breastfeeding and supports the normal physiological functions involved in this maternal-infant process. BC...»

«25) Prague Medical Report / Vol. 110 (2009) No. 1, p. 25–34 Somatic and Endocrinological Changes in Non Medicated ADHD Children Ptáček R., Kuželová H., Paclt I., Žukov I., Fischer S. Charles University in Prague, 1st Faculty of Medicine, Department of Psychiatry, Prague, Czech Republic Re c e i v e d D e c e m b e r 1 6, 2 0 0 8 ; A c c e p t e d M a r c h 2, 2 0 0 9. Key words: ADHD – Hyperactivity and attention disorders – Anthropometry – Growth – BMI – Psychological...»

«J. Anat. (1971), 108, 1, pp. 89-97 89 With 3 figures Printed in Great Britain Quantitative measurement on finite tissue sections J. R. PHILP AND T. J. BUCHANAN From the Departments of Therapeutics and Pharmacology and Medical Physics, University of Aberdeen, Scotland (Received 30 January 1970) INTRODUCTION Certain quantitative histological techniques are concerned with the determination of numbers, volumes and surface areas of three-dimensional tissue structures. In the course of some...»

«Final report for Project no. 1903 Minimising medicine use in organic dairy herds through animal health and welfare planning ANIPLAN Period covered: (Final: 01.07.2007 – 31.10.2010) Contract Contract no. 1903 ANIPLAN Acronym: Minimising medicine use in organic dairy herds through animal health and Contract title: welfare planning Coordinator information: University of Aarhus, Faculty of Institution: Acronym AU-DJF Agricultural Sciences Faculty/ Department/ Institute for Animal Biology and...»

«Castlecrag Branch DINNER WITH GLADYS BEREJIKLIAN MP STATE OF THE STATE REPORT Date: Wednesday, 29th March Time: 7pm for 7.30pm Cost: $65 per person, $50 YLs Private Dining Room, NSW Parliament House, Macquarie Street Sydney Enquiries: Denise Fischer 02 9958 8452 Greenwich Branch LUNCHEON WITH ANTHONY ROBERTS MEMBER FOR LANE COVE Date: Wednesday, 29th March Time: 12noon Cost: $45 two course luncheon Strangers Dining Room, NSW Parliament House, Macquarie Street Sydney Enquiries: Joan Robinson 02...»

«Research Strategies 20 (2006) 149 – 161 Patently Obvious: The place for patents in information literacy in the sciences Don MacMillan ⁎ Mackinnie Library, University of Calgary, 2500 University Drive, NW, Calgary, Alberta, Canada T2N 1N4 Available online 30 August 2006 Abstract Patents are an underutilized source of scientific information, particularly in the life and health sciences. Patents and patent applications usually contain the first disclosure of new technologies and processes and...»

«Unit 6: Aviation Geography and Terminology Unit code: T/504/2281 QCF Level 3: BTEC Nationals Credit value: 6 Guided learning hours: 36 Aim and purpose The aim of this unit is to give learners knowledge, understanding and skills to provide accurate and relevant information about airline routes, airport and flight information, climate and health. Unit introduction Any person wishing to work in the aviation industry needs to develop knowledge of the location of major destinations and airports...»

«HOME Welcome to the practice of Dr Amenah Shaikh. Located in Rondebosch East and Strand, our practice's top priority is to provide you the highest quality orthodontic care in a friendly, comfortable environment. We recognize that every patient has different needs, and we pride ourselves in the courteous service we deliver to each person who walks through our doors. Whether you're an adult, adolescent or child, we are knowledgeable and committed to helping you achieve the smile you deserve a...»

«JBC Papers in Press. Published on June 25, 2001 as Manuscript C100301200 Hydrophobic ligand binding by ZAG, a soluble fat-depleting factor related to MHC proteins* Malcolm W. Kennedy∆∞, Astrid P. Heikema, Alan Cooper||, Pamela J. Bjorkman and Luis M. Sanchez§ From the ∆Division of Environmental and Evolutionary Biology, Institute of Biomedical and Life Sciences, Downloaded from http://www.jbc.org/ by guest on November 16, 2016 University of Glasgow, Glasgow G12 8QQ, the Division of...»

«PEOPLE MEDICINE PEOPLE MEDICINE A Frugal Physician prescribes Common Sense and Enthusiasm by Robert McNary MD PEOPLE MEDICINE A Frugal Physician Prescribes Common Sense and Enthusiasm Copyright 2011 by Robert McNary All Rights Reserved Manufactured in the United States of America Editorial Assistance by Charlotte McDevitt Tracy Deliman Nicolas Ortiz Cue Cover and layout by Curt Perkins / Electric Avenue Nashville Published by The Portable School Press theportableschool@gmail.com...»

«THE REPEAL OF WASHINGTON'S INFANT TOLLING STATUTE IN MEDICAL MALPRACTICE CASES: STATE CONSTITUTIONAL CHALLENGES Cheryl L. Harner* I. INTRODUCTION Until 1986, the State of Washington was one of many jurisdictions with a tolling statute that suspended the statute of limitations period for minors until they reached majority.1 These statutes recognized a strongly held principle of the common law and our tort system: children are to be protected from the destruction of their rights by the running of...»

«Rab27b is expressed in a wide range of exocytic cells and involved in the delivery of secretory granules near the plasma membrane Hiroshi Gomi,* Kenichi Mori,* Shigeyoshi Itohara,† and Tetsuro Izumi*‡ *Laboratory of Molecular Endocrinology and Metabolism, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi 371-8512, Japan † Laboratory for Behavioral Genetics, Brain Science Institute, Institute of Physical and Chemical Reserch, Wako 351-0198, Japan ‡ Corresponding...»

<<  HOME   |    CONTACTS
2016 www.dissertation.xlibx.info - Dissertations, online materials

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.